Clinical trial
Noninvasive Monitoring to Predict Outcome in De Novo Kidney Transplant Recipients
NCT00308802 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Noninvasive Monitoring to Predict Outcome in De Novo Kidney Transplant Recipients
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2006
- Completion date
- July 31, 2011
- Enrollment
- 280 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplantation